A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

NCT05241613 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
28
Enrollment
INDUSTRY
Sponsor class

Stopped Subject benefit-risk ratio changes, sponsor decides to voluntarily terminate study

Conditions

Interventions

Sponsor

Accutar Biotechnology Inc